Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392171
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2006-10-24
Brief Title:
The Effects of Continuous 28-day 2828 Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day 528 Treatment P04601
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2009-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-24
First Submit QC Date:
October 24 2006
Study First Post Date:
2006-10-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL